首页> 外文期刊>Annals of hematology >Analysis of prognostic factors and comparison of prognostic scores in peripheral T cell lymphoma, not otherwise specified: a single-institution study of 105 Chinese patients
【24h】

Analysis of prognostic factors and comparison of prognostic scores in peripheral T cell lymphoma, not otherwise specified: a single-institution study of 105 Chinese patients

机译:另有特别说明的外周T细胞淋巴瘤的预后因素分析和预后评分比较:105例中国患者的单机构研究

获取原文
获取原文并翻译 | 示例
           

摘要

Peripheral T cell lymphoma, not otherwise specified (PTCL-NOS) is a heterogeneous subtype of non-Hodgkin's lymphoma. This study aims to better define the prognostic factors and compare the predictive value of the prognostic scores in Chinese patients with PTCL-NOS. One hundred and five patients diagnosed as PTCL-NOS from our institution were retrospectively studied and grouped according to four previously described prognostic scores [International Prognostic Index (IPI), Prognostic Index for PTCL-NOS (PIT), modified PIT (m-PIT), and International PTCL Project (IPTCLP)]. In addition to clinical parameters, peripheral lymphopenia and thrombocytopenia, serum Epstein-Barr virus positivity, and tumor Ki-67 were significantly associated with poor disease outcome. Multivariate analysis revealed that age > 60 years, poor performance status, elevated lactic dehydrogenase, and bone marrow involvement were independent adverse variables for survival. All prognostic scores were successful for survival estimation. Risk subgroups in IPI and PIT could be further discriminated by platelet count (IPTCLP factor) and Ki-67 (m-PIT factor), respectively. Together, patient- and tumor-specific characteristics may be incorporated in risk stratification of PTCL-NOS patients. The prognostic scores could be mutually active to improve their predictive value of disease outcome.
机译:周围T细胞淋巴瘤(未另作说明)(PTCL-NOS)是非霍奇金淋巴瘤的异质亚型。本研究旨在更好地定义预后因素,并比较中国PTCL-NOS患者预后评分的预测价值。根据先前描述的四个预后评分[国际预后指数(IPI),PTCL-NOS的预后指数(PIT),改良的PIT(m-PIT)”,对我院诊断为PTCL-NOS的105例患者进行回顾性研究和分组。 ,以及国际PTCL项目(​​IPTCLP)]。除临床参数外,外周淋巴细胞减少症和血小板减少症,血清爱泼斯坦-巴尔病毒阳性和肿瘤Ki-67与不良的疾病预后显着相关。多因素分析显示,年龄> 60岁,表现不佳,乳酸脱氢酶升高和骨髓受累是生存的独立不利变量。所有预后评分均能成功估计生存率。 IPI和PIT的危险亚组可以分别通过血小板计数(IPTCLP因子)和Ki-67(m-PIT因子)进一步区分。 PTCL-NOS患者的风险分层可能会结合患者和肿瘤的特定特征。预后评分可以相互促进,以提高其对疾病结局的预测价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号